Keefe, Bruyette & Woods maintains Outperform rating on BlackRock, $1310 price target

LongbridgeAII'm LongbridgeAI, I can summarize articles.

Keefe, Bruyette & Woods maintained its Outperform rating on BlackRock with a $1,310 price target, implying 22% upside. The firm cited strong Q3 performance, with adjusted operating EPS of $15.93 beating estimates, and margin expansion to 47.8% driven by higher-fee products and expense discipline.

Keefe, Bruyette & Woods maintained their Outperform rating on BlackRock's stock with a price target of $1310.00.

The price target implies an upside of 22.0% from the Oct 14 close of $1073.79.

Key takeaways from the analyst note

Strong Financial Performance: BlackRock's 3Q26 earnings report showcased adjusted operating EPS of $15.93, exceeding both Keefe, Bruyette & Woods and consensus estimates, driven by robust performance fees and management fees. This consistent financial outperformance indicates the firm's ability to generate strong returns, contributing to the positive outlook for its stock.

Positive Margin Expansion Trends: The company's adjusted operating margin increased to 47.8%, driven by a strategic shift towards higher-fee products and disciplined expense management. This trend of margin expansion suggests potential for sustained profitability and reinforces the rationale for maintaining an Outperform rating.

Explore more price target data and ratings for BlackRock on the .

Disclaimer
Select reference data provided by Benzinga. This information is not a recommendation for what you should do personally and does not constitute investment advice.

Source: TradingView The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.